CombinatoRx to Present at the BIO 2006 Chicago Annual International Convention
Posted on: Thursday, 6 April 2006, 15:00 CDT
CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that Robert Forrester, Chief Financial Officer, is scheduled to present in the upcoming BIO 2006 Chicago Annual International Convention held at the McCormick Place Convention Center in Chicago, IL. Mr. Forrester is scheduled to present on April 10, 2006 at 2:00 pm CST. Interested parties may access the live webcast of the presentation by visiting the CombinatoRx website at www.combinatorx.com.
About CombinatoRx
CombinatoRx, Incorporated is a biopharmaceutical company focused on developing new medicines built from synergistic combinations of approved drugs, designed to attack disease on multiple fronts. CombinatoRx applies its proprietary combination drug discovery technology to identify new combination product candidates in a number of disease areas, including immunoinflammatory disease, oncology, metabolic disease, neurodegenerative disease, and infectious disease. By applying our proprietary screening technology, we have discovered and advanced into clinical trials a portfolio of six product candidates targeting multiple diseases. For further information, please visit the CombinatoRx website at www.combinatorx.com.
Forward-Looking Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning CombinatoRx, its plans for its product candidates, and plans for other research and development programs. These forward-looking statements involve significant risks, uncertainties and assumptions, including those discussed in this release and others that can be found in the "Risk Factors" section of CombinatoRx's Annual Report on Form 10-K on file with the Securities and Exchange Commission, and the other filings made by CombinatoRx with the Securities and Exchange Commission. No forward-looking statement can be guaranteed and actual results may differ materially from those CombinatoRx projects. CombinatoRx is providing this information as of this date and does not undertake any obligation to publicly update any forward-looking statements contained in this document as a result of new information, future events or otherwise, except as required by law.
(c) 2006 CombinatoRx, Incorporated. All rights reserved.
Source: Business Wire
Related Articles
- Allied Security Innovations Products Secure Voting Machines Across USA
- Hard To Treat Diseases (HTDS) Launches On Line Cosmetics Products
- Devon Energy Provides Forward-Looking Estimates of Production, Reserve Additions and Capital Expenditures
- ''Sentry Remote(TM)'' Named ''2006 Outstanding Product'' By iParenting Media; Award Panel Highlights Ease-of-Use, Real-Time Monitoring and Control Features
- CombinatoRx to Present at Baird's 2006 Focus on Oncology Conference
- Open Energy Corporation Wins PCBC 2006 "Cool Product" Award for SolarSave(TM) Roofing Membrane System
- CombinatoRx Discontinues CRx-140 As an Oral Product Candidate For Psoriasis
- VIOXX(R) Trial Update: Statement on VIOXX(R) Product Liability Trial Scheduled in Starr County, Texas
- EnCana Looks to Expand Oilsands Production to 500,000 Barrels Per Day
- Energen Hedges Another 5 BCF of 2006 Gas Production; Earnings Guidance Range Increased 10 Cents
 |
 |
User Comments (0)
RSS Feeds